This program has already taken place.This was a practical and clinically relevant meeting for the entire head and neck cancer community that provided the most up-to-date information on multidisciplinary therapies, the latest clinical research, new treatment strategies, supportive care, scientific breakthroughs and toxicity mitigation.SITC designated Course Director for the session, Robert Ferris, MD, PhD, FACS, moderated, "Immunotherapy Advances in Head and Neck Cancer," on Saturday, February 17, 2018 from 8 - 9:30 a.m. MT.
Other Highlights included:
Join
Renew
Member Directory
My Profile
Email Sign-up
Volunteer
Support SITC
Contact Us